477
Views
14
CrossRef citations to date
0
Altmetric
Laboratory Study

Poly (ADP-Ribose) Polymerase as a Potential Target for the Treatment of Acute Renal Injury Caused by Lipopolysaccharide

, , &
Pages 115-120 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tian-Biao Zhou & Zong-Pei Jiang. (2014) Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases. Journal of Receptors and Signal Transduction 34:3, pages 143-148.
Read now
Emin Oztas, Ahmet Guven, Erdal Turk, Bulent Uysal, Emin Ozgur Akgul, Tuncer Cayci, Nail Ersoz & Ahmet Korkmaz. (2009) 3-Aminobenzamide, a Poly ADP Ribose Polymerase Inhibitor, Attenuates Renal Ischemia/Reperfusion Injury. Renal Failure 31:5, pages 393-399.
Read now

Articles from other publishers (12)

Shuo Wang & Cheng Yang. 2018. Current Understanding of Apoptosis - Programmed Cell Death. Current Understanding of Apoptosis - Programmed Cell Death.
C. Celik-Ozenci, N. Kuscu, N. E. Gungor-Ordueri, A. Tasatargil, P. Sahin & H. Durmus. (2017) Inhibition of poly(ADP-ribose) polymerase may have preventive potential for varicocoele-associated testicular damage in rats. Andrology 5:2, pages 362-369.
Crossref
Xiaoying Xu, Linfeng Gou, Meng Zhou, Fusheng Yang, Yihan Zhao, Tingting Feng, Peikun Shi, Armin Ghavamian, Weiming Zhao, Yuan Yu, Yi Lu, Fan Yi, Guangyi Liu & Wei Tang. (2016) Progranulin protects against endotoxin-induced acute kidney injury by downregulating renal cell death and inflammatory responses in mice. International Immunopharmacology 38, pages 409-419.
Crossref
Jesper Kers, Jaklien C. Leemans & Andreas Linkermann. (2016) An Overview of Pathways of Regulated Necrosis in Acute Kidney Injury. Seminars in Nephrology 36:3, pages 139-152.
Crossref
Kunal Kapoor, Esha Singla, Bijayani Sahu & Amarjit S. Naura. (2014) PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice. Molecular and Cellular Biochemistry 400:1-2, pages 153-162.
Crossref
May Khin Hnin Si, Chieko Mitaka, Miniwan Tulafu, Shinya Abe, Masanobu Kitagawa, Satoshi Ikeda, Yoshinobu Eishi, Shunichi Kurata & Makoto Tomita. (2013) Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats. Respiratory Research 14:1.
Crossref
Nicola J. Curtin & Csaba Szabo. (2013) Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond. Molecular Aspects of Medicine 34:6, pages 1217-1256.
Crossref
Selvinaz Dalaklioglu, Pinar Sahin, Ece Gungor Ordueri, Ciler Celik-Ozenci & Arda Tasatargil. (2012) Potential Role of Poly(ADP-Ribose) Polymerase (PARP) Activation in Methotrexate-Induced Nephrotoxicity and Tubular Apoptosis. International Journal of Toxicology 31:5, pages 430-440.
Crossref
S. N. Heyman, R. G. Evans, S. Rosen & C. Rosenberger. (2012) Cellular adaptive changes in AKI: mitigating renal hypoxic injury. Nephrology Dialysis Transplantation 27:5, pages 1721-1728.
Crossref
Premila Abraham & Suganthy Rabi. (2011) Aminoguanidine, a Selective Nitric Oxide Synthase Inhibitor, Attenuates Cyclophosphamide-Induced Renal Damage by Inhibiting Protein Nitration and Poly(ADP-Ribose) Polymerase Activation. Chemotherapy 57:4, pages 327-334.
Crossref
Selvinaz Dalaklioglu, Merih Tekcan, Nazli Ece Gungor, Ciler Celik-Ozenci, Nazif Hikmet Aksoy, Asli Baykal & Arda Tasatargil. (2010) Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicology Letters 192:2, pages 91-96.
Crossref
Arda TasatargilMerih Tekcan, Ciler Celik-Ozenci, Nazli Ece Gungor & Bedriniam Dalkiran. (2009) Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation. Journal of the Renin-Angiotensin-Aldosterone System 10:3, pages 127-137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.